Search

everythinglearnresearchcommunity

for

Search:↓

At least 87% of Indian men experience hair loss, with type II being most common and severity increasing with age.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Female pattern hair loss treatments vary in effectiveness and may have side effects.

Finasteride can cause enlarged breasts.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Combining mood stabilizers with antipsychotics is more effective for treating children with bipolar disorder than using mood stabilizers alone.

Inflammation around hair follicles leads to hair loss, and treatments should focus on reducing this inflammation and other factors for effectiveness.

Washing test helps identify hair loss type, low iron levels significant.

SLE and DM can coexist but are rare and need careful evaluation.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

Spironolactone is a safe and effective treatment for reducing excessive hair growth in women.

Hair loss in men is common, treatable, but not curable.

K_ATP channel gene mutations are linked to heart diseases, but more research is needed to understand the connection and treatment potential.

Horizontally sectioned scalp biopsies are more reliable for diagnosing hair loss in women when three samples are taken instead of one.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Psoriasis skin changes are complex and might need several biopsies for a clear diagnosis.

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.

Choosing the right model order in brain connectivity analysis can affect the detection of differences between healthy individuals and those with seasonal affective disorder.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Hair loss that spreads out can often fix itself or be treated by finding and handling the cause.

Choosing the right recall period for patient feedback is important for accurate data and depends on the disease, symptom changes, and patient impact.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.